Overall, companies should be adjusting their strategies to accommodate the GLP-1 trend, potentially emphasizing portion control, premiumization, and considering the effects of GLP-1 drugs on potential mergers and acquisitions
They don't just exist side-by-side
The price covers your medication regardless of schedule adjustments your provider recommends
Methotrexatebest response in subacute CLE and discoid CLE Immunosuppressives such as azathioprine, mycophenolate and cyclophosphamide Intravenous immunoglobulin Aspirin is recommended for antiphospholipid syndrome
Potential risks include infection, scarring, changes in nipple sensation, difficulty breastfeeding, asymmetry, and in rare cases, partial or total loss of the nipple or areola